SEC Form 4 · accession 0001493152-26-037351
TAKEDA PHARMACEUTICAL CO LTD · TAK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicola Deidre Petal Greenway
Officer — Chief Human Resources Officer
Period of report
Aug 10, 2026
Accepted (ET)
Aug 12, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001395064
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Aug 10, 2026 | S | 975 | $17.50 | D | 93,431 | D | |
| American Depositary Shares | Aug 10, 2026 | S | 33,628 | $17.5067 | D | 59,803 | D |
Table II — derivative securities
No Table II lines on this filing.